Liberty Wealth Management »

Brainstorm Cell Therapeutics shares owned by Liberty Wealth Management

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Liberty Wealth Management from 13F filings

Historical chart of Liberty Wealth Management investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Liberty Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Liberty Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $94k 340k 0.28
2023-09-30 $71k 353k 0.20
2023-06-30 $310k 151k 2.06
2023-03-31 $496k 150k 3.30
2022-09-30 $176k 40k 4.40
2022-06-30 $82k 30k 2.73

More positions owned by Liberty Wealth Management

iShares S&P 500 Index (IVV)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Us High Profitab (DUHP)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Apple (AAPL)
Ishares Msci Usa Quality Facto invalid (QUAL)
4068594 Enphase Energy (ENPH)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Core Fixed Incomeed Incom (DFCF)
Ishares Tr core tl usd bd (IUSB)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Vanguard Index Fds Total Stk Mkt (VTI)
iShares MSCI EAFE Value Index (EFV)
Ishares Tr Core Msci Eafe (IEFA)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)

View all positions for Liberty Wealth Management

Top funds holding Brainstorm Cell Therapeutics

Vanguard Group
Liberty Wealth Management
Weaver Consulting Group
Caldwell Sutter Capital
Abner, Herrman & BrocK
Raymond James & Associates
ADAR1 Capital Management
Ikarian Capital
Kingswood Wealth Advisors
Citadel Advisors
Virtu Financial
Jmac Enterprises
Barclays
Wells Fargo & Company
Saxony Capital Management

View all funds holding Brainstorm Cell Therapeutics